Chargement en cours...
In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae
OBJECTIVES: Increased antimicrobial resistance surveillance and new effective antimicrobials are crucial to maintain treatable gonorrhoea. We examined the in vitro activity of gepotidacin, a novel triazaacenaphthylene, and the effect of efflux pump inactivation on clinical Neisseria gonorrhoeae isol...
Enregistré dans:
| Publié dans: | J Antimicrob Chemother |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927889/ https://ncbi.nlm.nih.gov/pubmed/29796611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky162 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|